Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies (Q26865740)

Fabiana D. S. Alves

series ordinal

2

1 reference

language of work or name

1 reference

January 2014

1 reference

Journal of Neurochemistry

published in

1 reference

volume

128

1 reference

issue

1

1 reference

page(s)

1-87

1 reference

Neural damage in the lenticular nucleus linked with tardive dyskinesia in schizophrenia: a preliminary study using proton magnetic resonance spectroscopy

cites work

1 reference

Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation

21 January 2018

1 reference

Quantitative proton MR spectroscopy findings in the corpus callosum of patients with schizophrenia suggest callosal disconnection

21 January 2018

1 reference

Altered metabolic integrity of corpus callosum among individuals at ultra high risk of schizophrenia and first-episode patients

21 January 2018

1 reference

Factors affecting the quantification of short echo in-vivo 1H MR spectra: prior knowledge, peak elimination, and filtering

21 January 2018

1 reference

Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study

21 January 2018

1 reference

Proton magnetic resonance spectroscopy in schizophrenia

21 January 2018

1 reference

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

21 January 2018

1 reference

Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder

21 January 2018

1 reference

In vivo quantification of intracerebral GABA by single-voxel (1)H-MRS-How reproducible are the results?

21 January 2018

1 reference

Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia

21 January 2018

1 reference

Absolute metabolite concentrations calibrated using the total water signal in brain (1)H MRS.

21 January 2018

1 reference

Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia

21 January 2018

1 reference

1H-MRS at 4 tesla in minimally treated early schizophrenia

21 January 2018

1 reference

Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.

21 January 2018

1 reference

The thalamus and schizophrenia: current status of research

21 January 2018

1 reference

Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype

21 January 2018

1 reference

Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia

21 January 2018

1 reference

Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression

21 January 2018

1 reference

Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction

21 January 2018

1 reference

Sex differences in regional gray matter in healthy individuals aged 44-48 years: a voxel-based morphometric study

21 January 2018

1 reference

N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction

21 January 2018

1 reference

Evolving knowledge of sex differences in brain structure, function, and chemistry

21 January 2018

1 reference

Abnormalities of thalamic volume and shape in schizophrenia

21 January 2018

1 reference

Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders

21 January 2018

1 reference

Evidence for altered cerebellar vermis neuronal integrity in schizophrenia

21 January 2018

1 reference

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

21 January 2018

1 reference

Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9.

21 January 2018

1 reference

Meta-analysis of diffusion tensor imaging studies in schizophrenia

21 January 2018

1 reference

Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study

21 January 2018

1 reference

Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia

21 January 2018

1 reference

The NMDA receptor hypofunction model of psychosis

21 January 2018

1 reference

Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder

21 January 2018

1 reference

Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo.

21 January 2018

1 reference

Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis

21 January 2018

1 reference

Female specific anterior cingulate abnormality and its association with empathic disability in schizophrenia

21 January 2018

1 reference

Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis

21 January 2018

1 reference

Multimodal functional imaging investigation before and after the onset of psychosis

21 January 2018

1 reference

Nuclear magnetic resonance and its applications to physiological problems

21 January 2018

1 reference

Basal ganglia N-acetylaspartate correlates with the performance in the procedural task 'Tower of Hanoi' of neuroleptic-naive schizophrenic patients

21 January 2018

1 reference

Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.

21 January 2018

1 reference

No alterations of brain GABA after 6months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia

21 January 2018

1 reference

Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls

21 January 2018

1 reference

Proton NMR chemical shifts and coupling constants for brain metabolites

21 January 2018

1 reference

(1)H MR spectroscopy. Methods and applications in diagnosis and assessment of surgical and conservative treatment strategies in epilepsies

21 January 2018

1 reference

Multivoxel proton MR spectroscopy used to distinguish anterior cingulate metabolic abnormalities in patients with schizophrenia

21 January 2018

1 reference

Hippocampal integrity and neurocognition in first-episode schizophrenia: a multidimensional study.

21 January 2018

1 reference

Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.

21 January 2018

1 reference

Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia

21 January 2018

1 reference

Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies

21 January 2018

1 reference

Measurement of brain glutamate using TE-averaged PRESS at 3T.

21 January 2018

1 reference

N-acetylaspartate reductions in the mediodorsal and anterior thalamus in men with schizophrenia verified by tissue volume corrected proton MRSI.

21 January 2018

1 reference

1 H MR Spectroscopy of the Brain: Absolute Quantification of Metabolites 1

21 January 2018

1 reference

Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.

21 January 2018

1 reference

N-acetylaspartylglutamate (NAAG) and N-acetylaspartate (NAA) in patients with schizophrenia

21 January 2018

1 reference

From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.

21 January 2018

1 reference

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy

21 January 2018

1 reference

Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: a combined MRI and 1H-MRS study

21 January 2018

1 reference

Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts

21 January 2018

1 reference

Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy

21 January 2018

1 reference

Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects

21 January 2018

1 reference

Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy

21 January 2018

1 reference

Neuroanatomical differences between familial and sporadic schizophrenia and their parents: an optimized voxel-based morphometry study

21 January 2018

1 reference

Proton MRS in twin pairs discordant for schizophrenia

21 January 2018

1 reference

Basal ganglia shape abnormalities in the unaffected siblings of schizophrenia patients

21 January 2018

1 reference

Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia

21 January 2018

1 reference

Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study

21 January 2018

1 reference

Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI).

21 January 2018

1 reference

Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra

21 January 2018

1 reference

Proton magnetic resonance spectroscopy (1H-MRS) of hippocampus, basal ganglia, and vermis of cerebellum in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).

21 January 2018

1 reference

N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration

21 January 2018

1 reference

Mesial temporal lobe Cho to Cr(PCr) ratio asymmetry in chronic schizophrenics

21 January 2018

1 reference

Structural neuroimaging in adolescents with a first psychotic episode

21 January 2018

1 reference

Three-dimensional mapping of temporo-limbic regions and the lateral ventricles in schizophrenia: gender effects

21 January 2018

1 reference

Magnetic resonance spectroscopy of neurotransmitters in human brain.

21 January 2018

1 reference

Proton magnetic resonance spectroscopy of lenticular nuclei in simple schizophrenia.

21 January 2018

1 reference

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

21 January 2018

1 reference

Learning potential on the WCST in schizophrenia is related to the neuronal integrity of the anterior cingulate cortex as measured by proton magnetic resonance spectroscopy.

21 January 2018

1 reference

1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia

21 January 2018

1 reference

Creatine abnormalities in schizophrenia and bipolar disorder

21 January 2018

1 reference

T2 relaxation time abnormalities in bipolar disorder and schizophrenia

21 January 2018

1 reference

Elevated gamma-aminobutyric acid levels in chronic schizophrenia

21 January 2018

1 reference

Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation.

21 January 2018

1 reference

In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging

21 January 2018

1 reference

Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain

21 January 2018

1 reference

Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS.

21 January 2018

1 reference

Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia

21 January 2018

1 reference

Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.

21 January 2018

1 reference

Progression of brain volume changes in adolescent-onset psychosis

21 January 2018

1 reference

Brain development, gender and IQ in children. A volumetric imaging study

21 January 2018

1 reference

In vivo nuclear magnetic resonance spectroscopy studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics

21 January 2018

1 reference

Proton magnetic resonance spectroscopy (H-MRS) studies of schizophrenia.

21 January 2018

1 reference

White matter alterations in deficit schizophrenia.

21 January 2018

1 reference

Neurochemical and structural correlates of executive dysfunction in schizophrenia

21 January 2018

1 reference

Proton magnetic resonance spectroscopy of the frontal lobe in schizophrenics: a critical review of the methodology

21 January 2018

1 reference

Proton magnetic resonance spectroscopy of the frontal, cingulate and perirolandic cortices and its relationship to skin conductance in patients with schizophrenia

21 January 2018

1 reference

The principal features and mechanisms of dopamine modulation in the prefrontal cortex

21 January 2018

1 reference

Posterior cingulate gyrus metabolic changes in chronic schizophrenia with generalized cognitive deficits

21 January 2018

1 reference

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

21 January 2018

1 reference

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.

21 January 2018

1 reference

Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study

21 January 2018

1 reference

Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls

21 January 2018

1 reference

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.

21 January 2018

1 reference

MRI T2 relaxation times of brain regions in schizophrenic patients and control subjects

21 January 2018

1 reference

Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment

21 January 2018

1 reference

Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls

21 January 2018

1 reference

Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).

21 January 2018

1 reference

GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

21 January 2018

1 reference

Regarding "Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study".

21 January 2018

1 reference

Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia

21 January 2018

1 reference

3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia

21 January 2018

1 reference

In vivo 1H NMR spectroscopy of the human brain at 7 T.

21 January 2018

1 reference

Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes

21 January 2018

1 reference

MR spectroscopic evaluation of N-acetylaspartate's T2 relaxation time and concentration corroborates white matter abnormalities in schizophrenia

21 January 2018

1 reference

Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies

21 January 2018

1 reference

Release of arginine, glutamate and glutamine in the hippocampus of freely moving rats: Involvement of nitric oxide

21 January 2018

1 reference

A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia

21 January 2018

1 reference

In vivo measurement of T2 distributions and water contents in normal human brain

21 January 2018

1 reference

Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations

21 January 2018

1 reference

A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis

21 January 2018

1 reference

Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation

21 January 2018

1 reference

Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia

21 January 2018

1 reference

1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia

21 January 2018

1 reference

Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.

21 January 2018

1 reference

GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression

21 January 2018

1 reference

Hemispheric and gender-related differences in the gross morphology of the anterior cingulate/paracingulate cortex in normal volunteers: an MRI morphometric study

21 January 2018

1 reference

A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction.

21 January 2018

1 reference

Human brain-structure resolved T(2) relaxation times of proton metabolites at 3 Tesla

21 January 2018

1 reference

Findings of proton magnetic resonance spectometry in the dorsolateral prefrontal cortex in adolescents with first episodes of psychosis

21 January 2018

1 reference

Frontal, temporal, and striatal proton relaxation times in schizophrenic patients and normal comparison subjects

21 January 2018

1 reference

Selective Relationship Between PrefrontalN-Acetylaspartate Measures and Negative Symptoms in Schizophrenia

21 January 2018

1 reference

Thalamic Shape Abnormalities in Individuals with Schizophrenia and Their Nonpsychotic Siblings

21 January 2018

1 reference

Altered White Matter/Gray Matter Proportions in the Striatum of Patients With Schizophrenia: A Volumetric MRI Study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JNC.12398

0 references

PubMed publication ID

23937509

1 reference